Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Cellebrite DI Ltd.

Stage 4 · Declining · week 9

As of Oct 22, 2026, Cellebrite DI is in Stage 4, the downtrend phase, now in week 9 (since Aug 26, 2026). It closed at $11.79, 38.8% below its 52-week high and below its 200-day average, which is falling.

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. More about the company

$11.79
+3.88% today
$3.0B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is CLBT early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 25w
S2 36w
S4 18w
S4 18w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 9w → S3 6w → S2 25w → S3 5w → S2 36w → S3 8w → S4 18w → S1 9w → S2 5w → S3 5w → S2 1w → S3 3w → S4 18w → S1 8w → S4 8w current
Total tracked: 165 weeks across 15 stage runs.

CLBT among Software - Infrastructure93rd of 179 by relative strength

All 179 →
Stocks in Software - Infrastructure ranked by relative strength, with stage and one-month change
#StockStageRS1M
1PAYSStage 2 · wk 2397+20.0%
2BANDStage 3 · wk 1197−31.5%
3USIOStage 2 · wk 1996+39.2%
4OKTAStage 2 · wk 1996−2.0%
5TWLOStage 2 · wk 2696−12.8%
6DOCNStage 2 · wk 396−34.8%
7GCTStage 2 · wk 996+12.6%
8FTNTStage 2 · wk 2495−3.2%
…93CLBTStage 4 · wk 930+2.5%
vs 52W High
-38.8%
$10.44 lo$19.28 hi
38.8% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 9
1w13w26w
Week 9, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-13.2%
200 DMA: $13.58 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.40x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+2.5%
3M
-17.1%
6M
-7.4%
YTD
-33.9%
1Y
-36.3%
Scan Membership
Breakout Watch
Latest: 2024-06-26
6 appearances in last 60 days. First seen: 2021-09-24.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 9 · Vol 0.40x
2026-10-21S4
Wk 8 · Vol 0.21x
2026-10-20S4
Wk 8 · Vol 0.36x
2026-10-19S4
Wk 8 · Vol 0.29x
2026-10-16S4
Wk 8 · Vol 0.43x
2026-10-15S4
Wk 8 · Vol 0.75x
2026-10-14S4
Wk 7 · Vol 0.57x
2026-10-13S4
Wk 7 · Vol 0.64x
2026-10-12S4
Wk 7 · Vol 0.47x
2026-10-09S4
Wk 7 · Vol 0.41x
2026-10-08S4
Wk 7 · Vol 0.31x
2026-10-07S4
Wk 6 · Vol 0.54x
Moving averages & range
50 DMA
$11.36
200 DMA
$13.58
52W High
$19.28
52W Low
$10.44
5D Low
$11.03
Resistance levels (recent highs)
20d High
$11.79
60d High
$16.03
120d High
$16.61
250d High
$19.28
Next resistance
+36.0%
to 60d High
P/E (TTM)
51.3
Forward 18.0
Earnings Growth (YoY)
-67.9%
Revenue +15.8%
ROE
+12.4%
Profit margin +11.4%
Dividend Yield
0.00%
P/B 5.5

Cellebrite DI: quick answers

What stage is Cellebrite DI in?

As of Oct 22, 2026, Cellebrite DI (CLBT) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 26, 2026 and is in week 9. What the four stages mean

Is Cellebrite DI in an uptrend?

No. Cellebrite DI is in a Stage 4 downtrend. It trades 13.2% below its 200-day average, which is falling.

How far is Cellebrite DI from its 52-week high?

Cellebrite DI closed at $11.79 on Oct 22, 2026, 38.8% below its 52-week high of $19.28. Its 52-week low is $10.44.

How has Cellebrite DI performed over the past year?

As of Oct 22, 2026, Cellebrite DI is down 36.3% over the past year and down 33.9% so far in 2026.

Which sector and industry is Cellebrite DI in?

Cellebrite DI is in the Software - Infrastructure industry, part of the Information Technology sector.

About this companyInformation Technology· Software - Infrastructure

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.